Concepedia

John P. Parisot

JP

17

Publications

1.4K

Citations

15

H-Index

1995

Active since

Affiliations

The University of Melbourne(Current)

Walter and Eliza Hall Institute of Medical Research

Peter MacCallum Cancer Centre

Monash University

University of Dundee

John P. Parisot is an author at The University of Melbourne specializing in medicine, drug discovery, and cell biology.

Top concepts

MedicineDrug DiscoveryCell BiologyPharmacologyRadiation OncologyTumor BiologyCancer ResearchNatural SciencesHigh-throughput ScreeningCancer Biology

Publications per year

1995–2015

17

Publications

17

Structure-guided design of a selective BCL-XL inhibitor

Guillaume Lessène, Peter E. Czabotar, Brad E. Sleebs et al. · Nature Chemical Biology · 2013 · 370 citations · Full text

Drug Target, Medicine, Rational Drug Design +4

Sequence artefacts in a prospective series of formalin-fixed tumours tested for mutations in hotspot regions by massively parallel sequencing

Stephen Q. Wong, Jason Li, Angela Tan et al. · BMC Medical Genomics · 2014 · 248 citations · Full text

An <i>in vivo</i> large-scale chemical screening platform using <i>Drosophila</i> for anti-cancer drug discovery

Lee Willoughby, Tanja Schlosser, Samuel A. Manning et al. · Disease Models & Mechanisms · 2012 · 133 citations · Full text

Drug Target, Hit Identification, Pyrimidine Biosynthesis +16

Altered expression of the IGF-1 receptor in a tamoxifen-resistant human breast cancer cell line

John P. Parisot, Xiangdong Hu, Mario DeLuise et al. · British Journal of Cancer · 1999 · 87 citations · Full text

Breast Oncology, Altered Expression, Medicine +10

MRP1 not MDR1 gene expression is the predominant mechanism of acquired multidrug resistance in two prostate carcinoma cell lines

John Zalcberg, Hu Xf, A Slater et al. · Prostate Cancer and Prostatic Diseases · 2000 · 73 citations · Full text

Multidrug Resistance, Tumor Suppressor, Prostatic Disease +4

Rows per page

1–5 of 17